Cefovecin sodium is a broad-spectrum, third-generation cephalosporin antibiotic administered via subcutaneous injection to treat skin infections in dogs and cats caused by pathogens such as Pasteurella… Read more
Cefovecin sodium is a broad-spectrum, third-generation cephalosporin antibiotic administered via subcutaneous injection to treat skin infections in dogs and cats caused by pathogens such as Pasteurella multocida, Staphylococcus intermedius, and Streptococcus canis. This category contains high-quality reference standards for the active pharmaceutical ingredient, alongside essential pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for critical analytical testing, including impurity profiling, method development, and rigorous quality control protocols. By providing access to these specialized compounds, researchers can ensure accurate identification and quantification of degradation products or synthesis-related impurities, supporting the validation of analytical methods for this veterinary therapeutic agent. These materials are indispensable for maintaining the integrity and compliance of drug products throughout their development and regulatory lifecycle.